Immunic, Inc. Common Stock (IMUX)
Immunic, Inc. Common Stock (IMUX) has a 18-report earnings history dating back to Aug 06, 2021. Its average absolute post-earnings move is ±6.26%, and 50.0% of those reactions were positive. Its largest post-earnings gain was +22.7% (Aug 04, 2022) and its largest decline was -9.32% (Feb 24, 2022). The next earnings report is predicted for 2026-08-07 (estimated).
Earnings reactions
How IMUX moved on each past earnings report.
Earnings Impact
Total Earnings
18
Avg Abs. Movement
±6.26%
Positive %
50.0%
Negative %
50.0%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 13, 2026 | ☀ PRE | +9.7% | open_in_new |
| Feb 26, 2026 | ☀ PRE | +4.27% | open_in_new |
| Nov 13, 2025 | ☀ PRE | -6.37% | open_in_new |
| Aug 07, 2025 | ☀ PRE | -7.68% | open_in_new |
Earnings Count
18
Total earnings in dataset
Avg Abs. Movement
±6.26%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| SCHEDULE 13G/A | 20260716 | open_in_new SEC.gov |
| 8-K | 20260714 | open_in_new SEC.gov |
| 4 | 20260707 | open_in_new SEC.gov |
| 4 | 20260707 | open_in_new SEC.gov |
| 4 | 20260707 | open_in_new SEC.gov |
| 4 | 20260707 | open_in_new SEC.gov |
| 4 | 20260707 | open_in_new SEC.gov |
| 8-K | 20260706 | open_in_new SEC.gov |
| 4 | 20260629 | open_in_new SEC.gov |
| 4 | 20260629 | open_in_new SEC.gov |
Frequently asked about IMUX earnings
When does Immunic, Inc. Common Stock report earnings next? expand_more
Immunic, Inc. Common Stock (IMUX)'s next earnings date is estimated for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does IMUX stock move after earnings? expand_more
Over 18 reports, IMUX has moved an average of ±6.26% the session after earnings, closing higher 50.0% of the time.
What was IMUX's biggest post-earnings move? expand_more
IMUX's largest post-earnings gain on record was +22.7% on Aug 04, 2022, and its largest decline was -9.32% on Feb 24, 2022.
Where can I find Immunic, Inc. Common Stock's SEC filings? expand_more
All of Immunic, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- ALAMO GROUP INC (ALG) earnings 2026-08-04
- Aligos Therapeutics, Inc. Common Stock (ALGS) earnings 2026-08-05
- AbCellera Biologics Inc. Common Shares (ABCL) earnings 2026-08-05
- Airbnb (ABNB) earnings 2026-08-05
- Arcosa, Inc. (ACA) earnings 2026-08-04
- ACADIA PHARMACEUTICALS INC (ACAD) earnings 2026-08-05
- ACCO BRANDS Corp (ACCO) earnings 2026-08-04
- ProFrac Holding Corp. (ACDC) earnings 2026-08-07